Posts Tagged ‘tremors’

Shy children now candidates for dangerous psychiatric drugs

Wednesday, October 5th, 2011

NaturalNews
By Elizabeth Walling
October 5, 2011

(NaturalNews) New guidelines for mental illness turn shyness in children from a personality trait into a mental disorder that warrants drug treatment. Drug companies already target children, who fidget too much in class or have trouble concentrating on their homework, with stimulant drugs for treating attention deficit disorder. Now children who sit too quietly or are more withdrawn than their peers will also be targeted with medication for social anxiety disorder or depression.

These new guidelines increase the likelihood that children, who tend to be quiet or sad, will be diagnosed with depression. And children who talk back to adults or lose their temper frequently may be diagnosed with what is called oppositional defiant disorder. A diagnose in either case will likely lead to treatment with powerful psychotropic drugs.

Serious Risks for Children who take Psychiatric Drugs

The idea of turning every spectrum of human emotion into some kind of mental disorder is not only absurd, but it also threatens the long-term mental and physical health of our children.

Millions of children are currently taking one or more behavior-altering medications, despite the fact that these drugs carry the risk of serious side effects. Some of these side effects include suicidal thinking, loss of appetite, nausea, insomnia, sedation, seizures, insulin resistance, acne, tremors, muscle stiffness and more.

Some psychologists also point out that simply drugging children for behaving out of the norm could actually be masking very serious underlying problems. Children, who are the victims of mental, physical or sexual abuse, will often exhibit behaviors such as shyness, sadness or being more withdrawn. These experts warn that trying to seek a quick-fix for negative emotions denies children what they truly need: long-term care and guidance.

Who stands to profit from expanding the guidelines for diagnosable mental disorders? The answer is quite simple: the pharmaceutical companies which manufacture the drugs for treating these conditions. However, when we start labeling children as disordered for simply being quieter than their peers or having an occasional angry outburst, we are stepping into dangerous territory that threatens the future of an entire generation and beyond.

Sources for this article include:

http://www.dailymail.co.uk/health/a…

http://www.telegraph.co.uk/health/h…

http://www.sciencedaily.com/release…

http://www.aboutourkids.org/article…

About the author:

Elizabeth Walling is a freelance writer specializing in health and family nutrition. She is a strong believer in natural living as a way to improve health and prevent modern disease. She enjoys thinking outside of the box and challenging common myths about health and wellness. You can visit her blog to learn more:
www.livingthenourishedlife.com/2009…

Read the article here:  http://www.naturalnews.com/033778_shy_children_psychiatric_drugs.html

« Return to news items


Share

Online database lets you research the side effects of common psychiatric drugs

Thursday, September 15th, 2011

Natural News – September 15, 2011

by M.K. Tyler

(NaturalNews) If you have ever seen a commercial for a pharmaceutical drug, you are probably familiar with the long list of dangerous side effects that are rattled off in the last five seconds of the advertisement, just after viewers are told how Drug “X” is going to save their lives, improve their memories or give them unlimited energy. What was that? Did he just say that pill might cause bleeding out of my eyes?

Drug companies do a great job – and spend a lot of money – to ensure that most consumers aren’t aware of the harmful side effects of common drugs prescribed for conditions like depression, heart disease, arthritis, ADHD or high blood pressure. Unfortunately, the result of this has created a society where the average person with a health problem is captivated by the promises delivered in clever advertising. There is a drug for everything? All I have to do is talk to my doctor? How convenient.

But what if there was a way to take back control of our lives and our health? What if, despite talking to your doctor, you still have questions or concerns about the safety of a drug?

The Citizens Commission on Human Rights International (CCHR) has a database that allows you to do just that. It’s called the Psychiatric Drug Database, and it allows consumers to research the potential side effects of common psychiatric drugs, such as Ritalin or Wellbutrin.

While the database is limited to psychiatric drugs, this type of public information portal represents a significant step in the right direction to help patients find unbiased information and make informed decisions about their health.

The database allows you to search by drug and will retrieve information about adverse reactions reported by patients who have taken the drug, international warnings and studies that have been done on the drug and what side effects different age groups or genders have experienced. For example, a search of the effects of Ritalin on 18-30 year old women retrieved 89 reported cases of adverse side effects.

These effects including anxiety, fatigue, hypertension, tremors, chest discomfort, nausea, panic attacks, cardiac murmurs, aggression, suicide attempts and completed suicides. The results are broken down by case and list specific symptoms and reactions caused by the drug in each reported case.

Another search of Zoloft and its effects on young children included cases of cerebral disorders, upper respiratory tract infections, sleep disorders, vertigo, hallucinations, psychomotor hyperactivity and suicidal ideation.

The database only includes information on cases that were actually reported to the FDA’s Adverse Event Reporting System between 2004 and 2008. Based on the FDA’s own estimates, only about 1 to 10 percent of adverse drug side effects are even reported to the FDA. The CCHR’s database, therefore, represents only a small margin of the population that has been affected by adverse side effects of pharmaceutical psychiatric drugs.

Visitors to the site will also notice an interesting anecdote that describes how the definition of poison – a substance that causes death or harm when consumed by a living organism – clearly characterizes the drugs listed in the database. Consumers are encouraged to research potential problems of a drug before agreeing with their doctors to start a course of therapy.

To find more information about a particular drug, visit www.cchrint.org/psychdrugdangers

Sources for this article include

http://www.cchrint.org/psychdrugdan…

« Return to news items


Share

PTSD and Anti-Depressant Drugs: the Worst Notorious Modern Medical Fraud

Tuesday, September 21st, 2010

Salem-news.com

September 21, 2010

by Dr. Phillip Leveque

Afghanistan
Afghanistan by Tim King Salem-News.com

(MOLALLA, Ore.) – I’m sure some people will take umbrage at my title. Keep on reading. First of all there are about 30 of them – why? It’s easy, most don’t work. In fact placebos (fake sugar pills) frequently work better.

Another point, their adverse side effects are horrible. Some even cause worse depression and even suicide. The main side effects are nausea, insomnia, anxiety, restlessness, decreased sex drive, dizziness, weight gain or loss, tremors, sweating, sleepiness, fatigue, dry mouth, diarrhea, constipation, headache, et cetera. Who needs that stuff?!? They also screw up ones head and balance with falls and fractures. If one stops taking them, the withdrawal symptoms sound worse than heroin. In addition to all this, some are addicting and it is very difficult to stop taking them.

This kind of drug or drugs has an extremely interesting origin. Around 1950 the first drug in this class was actually an anti-tuberculosis drug Isoniazid. For some reason it also acted as a brain stimulant, much like amphetamine. When this side effect was published by the T.B. doctors, other doctors decided to try it on depression patients. Prior to this certain Morphine-like cousin drugs and amphetamines were used for depression. They had severe addiction liability.

Isoniazid, the T.B. drug, was used on an experimental basis and the patients brain function improved dramatically. The psychiatrists who read about this tried Isoniazid on their depression patients and they coined the word ANTI-DEPRESSANT.

From then on starting about 1957 the Tricyclic drugs were born. They were relatives of anti-histamine drugs and they did combat depression. I think the first well known one was Elavil which is still in use. This type of drug drifted around quietly for several years searching for a disease all of the sudden it erupted – CLINICAL DEPRESSION. The first REAL drug Fluoxetine or PROZAC came out in 1988 by Ely Lilly & Co. It was heavily advertised and we soon had a epidemic of clinical depression spread all over the world.

I’m not going into a recital of the various kinds of anti-depressants. I think there is enough to indicate that at least 500,000,000 prescriptions are written per year and for the 14 or so leaders, each is worth up to several billion dollars to the drug companies.

As I said in the beginning placebos, or fake pills, work about as well as these chemicals and exercise or just plain talking to a psychologist may work as well. The drug companies advertise heavily in the millions of dollars to sell these drugs to doctors and patients. It is worth it. The anti-depressants bring in billions of dollars.

A side comment is that the drug companies have sold the idea to the Veterans Administration and they prescribe these drugs by the ton to PTSD Veterans. The evidence is that they don’t help much and cause a lot of harm.

http://www.salem-news.com/articles/september212010/ptsd-depressants-pl.php

« Return to news items


Share

New Jersey Is Sued Over the Forced Medication of Patients at Psychiatric Hospitals

Tuesday, August 3rd, 2010

New York Times
by Richard Perez-Pena
August 3, 2010

Patient advocates filed a federal lawsuit on Tuesday charging that New Jersey psychiatric hospitals routinely medicate patients against their will without a review by an outside arbiter, a practice that is banned in most other states.

Twenty-nine states require a judge’s ruling for involuntary medication, according to the suit, including New York, Connecticut and other large states, like California, Florida and Texas. Five other states leave the decision to an individual or panel outside the hospital. Some states also provide an advocate to represent a patient in a hearing on forced medication.

But in New Jersey, state rules allow a patient in a state hospital to appeal medication decisions only to people in the hospital. The lawsuit contends that the internal appeal process is routinely ignored and that psychiatric patients in private hospitals lack any opportunity to appeal medication regimens at all.

The suit, filed in Federal District Court in Trenton by the group Disability Rights New Jersey, seeks a court order requiring the state to provide judicial review of involuntary medication. It notes that a prison inmate has more power to contest treatment decisions than a psychiatric patient.

The drugs forced on patients include powerful medications for conditions like schizophrenia and bipolar disorder. They help many people with those diseases function better, but can have serious side effects, including diabetes, tremors, seizures, high blood pressure, obesity, sedation, aches and impaired mental function.

“As a patient in a state hospital, it’s your legal right to refuse and go through a process, but you get severely penalized if you try,” said W. Emmett Dwyer, litigation director of Disability Rights New Jersey, a federally financed organization. “They view you as noncompliant with treatment. They give you an injection instead of a pill. And they tell you if you don’t take it, you won’t get out.”

There are about 1,800 patients at any given time in New Jersey’s five state psychiatric hospitals, and 1,000 in private ones.

Michael D. Reisman, a lawyer with Kirkland & Ellis, which is helping bring the lawsuit, said recent records from one state hospital showed that fewer than 20 percent of patients contested their medication.

But the advocates and several former patients said many more objected to their prescriptions but submitted quietly, rather than risk painful injections or a longer hospital stay. Others, they said, are too medicated to object.

“When I said no, they just shot me up instead, so pretty soon I gave up,” said Alice Hsia, 34, who has been in and out of hospitals for schizophrenia. “The times I was sedated, I would sign anything they wanted.”

Mr. Reisman said the question often was not whether some medication was needed, but rather one of dosage or a desire to try a “different drug with fewer side effects.” Some hospital

psychiatrists do not take such concerns seriously, he said, but “a judicial hearing would give the patient more leverage and force the doctors to listen.”

The State Department of Human Services, which runs the hospitals, declined to comment on the suit. But among advocates for the mentally ill, there are wide-ranging opinions on involuntary treatment.

Phil Lubitz, associate director of the National Alliance on Mental Illness of New Jersey,  said he did not see forced medication as a major issue, noting that it was extremely difficult to get patients committed in New Jersey, and that most who were presented “a danger to themselves or others.”

But Robert Davison, executive director of the Mental health Association of Essex County,  called New Jersey’s policy “beneath contempt.”

Yana Paskova for The New York Times

Joseph Cichowski said he would have challenged forced medication if he had the opportunity.

Nicole Bengiveno/The New York Times

Alice Hsia said she submitted to prescriptions at hospitals quietly rather than risk painful injections.

Read the entire article here: http://www.nytimes.com/2010/08/04/health/policy/04psych.html

« Return to news items


Share

FDA says Pfizer overdosed 13 children in antipsychotic drug trial

Tuesday, April 20th, 2010

Reuters
April 20, 2010

U.S. health regulators have warned Pfizer Inc. over a series of failures that led to the overdosing of at least 13 children in a clinical trial of its antipsychotic drug Geodon, according to a letter made public on Tuesday.

The FDA, in an April 9 warning letter to the world’s largest drugmaker, said Pfizer “failed to ensure proper monitoring of the investigation” for a product.

The agency did not name the drug in the public version of the letter, but Pfizer confirmed it related to the use of Geodon in children with bipolar disorder.

It said the company did not properly monitor the study and, “as a result of inadequate monitoring, widespread overdosing of study subjects at multiple study sites was neither detected nor corrected in a timely manner.”

Several children given overdoses experienced tremors, restless legs and other complications, the letter said.

Pfizer recognizes the issue’s seriousness and is committed to addressing the concerns, it said. Pfizer reported many items cited in the letter as many as four years ago, it said.

Since then it “has instituted several new measures designed to improve monitoring and execution of clinical trials, including our oversight of clinical investigators,” it said.

Read entire article:  http://www.reuters.com/article/idUSTRE63J4XQ20100420

« Return to news items


Share